Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $3.08 million. The enterprise value is -$2.51 million.
| Market Cap | 3.08M |
| Enterprise Value | -2.51M |
Important Dates
The last earnings date was Friday, August 14, 2026, before market open.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APVO has 1.80 million shares outstanding. The number of shares has increased by 7,302.27% in one year.
| Current Share Class | 1.80M |
| Shares Outstanding | 1.80M |
| Shares Change (YoY) | +7,302.27% |
| Shares Change (QoQ) | +12.79% |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | 5.42% |
| Float | 1.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.70.
| Current Ratio | 2.08 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -420.34% and return on invested capital (ROIC) is -154.28%.
| Return on Equity (ROE) | -420.34% |
| Return on Assets (ROA) | -111.49% |
| Return on Invested Capital (ROIC) | -154.28% |
| Return on Capital Employed (ROCE) | -288.14% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$803,182 |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.06% in the last 52 weeks. The beta is 1.61, so APVO's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -94.06% |
| 50-Day Moving Average | 3.75 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 23.33 |
| Average Volume (20 Days) | 178,556 |
Short Selling Information
The latest short interest is 81,745, so 4.54% of the outstanding shares have been sold short.
| Short Interest | 81,745 |
| Short Previous Month | 87,627 |
| Short % of Shares Out | 4.54% |
| Short % of Float | 4.82% |
| Short Ratio (days to cover) | 2.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.89M |
| Pretax Income | -26.41M |
| Net Income | -26.51M |
| EBITDA | -26.69M |
| EBIT | -26.89M |
| Earnings Per Share (EPS) | -$29.72 |
Balance Sheet
The company has $9.80 million in cash and $4.21 million in debt, with a net cash position of $5.59 million or $3.10 per share.
| Cash & Cash Equivalents | 9.80M |
| Total Debt | 4.21M |
| Net Cash | 5.59M |
| Net Cash Per Share | $3.10 |
| Equity (Book Value) | 6.04M |
| Book Value Per Share | 4.26 |
| Working Capital | 5.61M |
Cash Flow
| Operating Cash Flow | -25.34M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 197,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.34M |
| FCF Per Share | -$14.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7,302.27% |
| Shareholder Yield | -7,302.27% |
| Earnings Yield | -860.17% |
| FCF Yield | -822.46% |
Analyst Forecast
The average price target for APVO is $25.50, which is 1,391.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.50 |
| Price Target Difference | 1,391.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 30, 2025. It was a reverse split with a ratio of 1:18.
| Last Split Date | Dec 30, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |